Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.14B |
| 2 |
Microsoft
MSFT
|
+$2.98B |
| 3 |
UnitedHealth
UNH
|
+$2.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.59B |
| 5 |
CRH
CRH
|
+$2.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.01B |
| 2 |
Flutter Entertainment
FLUT
|
+$1.59B |
| 3 |
Welltower
WELL
|
+$841M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$798M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Universal Logistics Holdings
ULH
$353M
| $10.4M | ﹤0.01% |
397,012
+1,212
| +0.3% | +$41.4K |
|
2827
Dakota Gold
DC
$608M
| $10.4M | ﹤0.01% |
3,926,299
+383,180
| +11% | +$1.05M |
|
2828
Annexon
ANNX
$835M
| $10.4M | ﹤0.01% |
5,379,659
-167,259
| -3% | -$557K |
|
2829
LCNB Corp
LCNB
$282M
| $10.3M | ﹤0.01% |
699,101
+31,892
| +5% | +$479K |
|
|
DFTX
2830
Definium Therapeutics
DFTX
$5.78B
| $10.3M | ﹤0.01% |
1,766,547
-144,278
| -8% | -$1.03M |
|
|
ITOS
2831
DELISTED
iTeos Therapeutics
ITOS
| $10.3M | ﹤0.01% |
1,726,458
+92,429
| +6% | +$679K |
|
|
FVR
2832
FrontView REIT
FVR
$475M
| $10.3M | ﹤0.01% |
805,023
-1,646
| -0.2% | -$26.9K |
|
2833
LifeMD
LFMD
$169M
| $10.2M | ﹤0.01% |
1,880,505
+120,279
| +7% | +$682K |
|
2834
Bankwell Financial Group
BWFG
$543M
| $10.2M | ﹤0.01% |
338,071
-437
| -0.1% | -$13.3K |
|
2835
GigaCloud Technology
GCT
$1.63B
| $10.2M | ﹤0.01% |
718,108
+16,675
| +2% | +$304K |
|
2836
HF Foods Group
HFFG
$80.2M
| $10.2M | ﹤0.01% |
2,079,849
+71,001
| +4% | +$194K |
|
2837
Arteris
AIP
$1.38B
| $10.1M | ﹤0.01% |
1,468,593
-13,109
| -0.9% | -$125K |
|
2838
Hyliion Holdings
HYLN
$635M
| $10.1M | ﹤0.01% |
7,236,184
-17,855
| -0.2% | -$35.4K |
|
2839
Ring Energy
REI
$315M
| $10.1M | ﹤0.01% |
8,783,495
+1,597,414
| +22% | +$2.08M |
|
|
RAPT
2840
DELISTED
RAPT Therapeutics
RAPT
| $10.1M | ﹤0.01% |
1,034,850
+667,181
| +181% | +$6.56M |
|
2841
Parke Bancorp
PKBK
$401M
| $10.1M | ﹤0.01% |
535,405
+1,062
| +0.2% | +$20.6K |
|
|
SLRN
2842
DELISTED
ACELYRIN
SLRN
| $10.1M | ﹤0.01% |
4,079,706
-304
| -0% | -$723 |
|
2843
Eve Holding
EVEX
$808M
| $10.1M | ﹤0.01% |
3,030,904
+27,667
| +0.9% | +$120K |
|
2844
C&F Financial
CFFI
$268M
| $10M | ﹤0.01% |
148,881
| – | – |
|
2845
uniQure
QURE
$3.03B
| $10M | ﹤0.01% |
945,466
-161,135
| -15% | -$2.26M |
|
2846
Eledon Pharmaceuticals
ELDN
$261M
| $10M | ﹤0.01% |
2,953,127
+58,488
| +2% | +$241K |
|
2847
Park-Ohio Holdings
PKOH
$575M
| $9.95M | ﹤0.01% |
460,761
+1,090
| +0.2% | +$26.1K |
|
2848
eGain
EGAN
$187M
| $9.92M | ﹤0.01% |
2,044,587
-19,101
| -0.9% | -$108K |
|
2849
Spire Global
SPIR
$444M
| $9.91M | ﹤0.01% |
1,225,211
+120,729
| +11% | +$1.6M |
|
|
EVBN
2850
DELISTED
Evans Bancorp Inc
EVBN
| $9.89M | ﹤0.01% |
253,832
| – | – |
|
Similar funds
Vanguard Group's Q1 2025 Portfolio in Review
As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.9%. Vanguard Group opened 78 new positions and exited 91, leaving the 4,371-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
- Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
- Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
- Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
- Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
- Vanguard Group opened 78 new positions and closed 91 in Q1 2025.
- Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.